Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Oracle
ORCL
|
+$881M |
| 2 |
DoorDash
DASH
|
+$403M |
| 3 |
Amgen
AMGN
|
+$403M |
| 4 |
Amazon
AMZN
|
+$282M |
| 5 |
Applied Materials
AMAT
|
+$231M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$592M |
| 2 |
Workday
WDAY
|
+$580M |
| 3 |
United Parcel Service
UPS
|
+$468M |
| 4 |
Apple
AAPL
|
+$438M |
| 5 |
Atlassian
TEAM
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.97% |
| 2 | Healthcare | 19.05% |
| 3 | Consumer Discretionary | 10.13% |
| 4 | Financials | 9.7% |
| 5 | Industrials | 9.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
526
Bristol-Myers Squibb
BMY
$129B
| $24.7M | 0.01% |
455,532
-29,272
| -6% | -$1.49M |
|
|
MRUS
527
DELISTED
Merus
MRUS
| $24.4M | 0.01% |
542,580
+11,536
| +2% | +$468K |
|
528
iShares Core International Aggregate Bond Fund
IAGG
$10.9B
| $24.4M | 0.01% |
488,055
+72,497
| +17% | +$3.59M |
|
529
LKQ Corp
LKQ
$6.72B
| $24.2M | 0.01% |
454,010
+407,162
| +869% | +$20.2M |
|
530
Enpro
NPO
$6.26B
| $24.2M | 0.01% |
143,445
-1,641
| -1% | -$255K |
|
531
Goldman Sachs
GS
$289B
| $24.1M | 0.01% |
57,734
+1,002
| +2% | +$389K |
|
532
Solid Biosciences
SLDB
$792M
| $23.9M | 0.01% |
+1,808,440
| New | +$16.9M |
|
533
Trade Desk
TTD
$8.97B
| $23.9M | 0.01% |
272,898
-162
| -0.1% | -$12.3K |
|
534
RTX Corp
RTX
$290B
| $23.8M | 0.01% |
244,051
-46,309
| -16% | -$4.18M |
|
535
Cummins
CMI
$83.6B
| $23.8M | 0.01% |
80,727
+11,033
| +16% | +$2.84M |
|
536
Enovis
ENOV
$1.74B
| $23.6M | 0.01% |
378,020
+189,584
| +101% | +$11.3M |
|
537
McCormick & Company Non-Voting
MKC
$14B
| $23.1M | 0.01% |
300,468
-2,827
| -0.9% | -$192K |
|
|
JLQD
538
Janus Henderson Corporate Bond ETF
JLQD
$14.2M
| $23M | 0.01% |
552,873
-890
| -0.2% | -$36.9K |
|
539
Adient
ADNT
$1.69B
| $23M | 0.01% |
697,303
+227,810
| +49% | +$7.75M |
|
540
Novanta
NOVT
$4.91B
| $22.7M | 0.01% |
130,044
-14,256
| -10% | -$2.34M |
|
541
Agnico Eagle Mines
AEM
$72.2B
| $22.4M | 0.01% |
376,451
-40,775
| -10% | -$2.09M |
|
542
OneMain Financial
OMF
$7.27B
| $22.3M | 0.01% |
437,365
+17,214
| +4% | +$822K |
|
543
Collegium Pharmaceutical
COLL
$1.18B
| $21.9M | 0.01% |
563,405
-64,107
| -10% | -$2.24M |
|
544
Broadstone Net Lease
BNL
$4.25B
| $21.9M | 0.01% |
1,394,892
+857,141
| +159% | +$13.5M |
|
545
State Street SPDR S&P Biotech ETF
XBI
$10B
| $21.7M | 0.01% |
228,861
-1,284
| -0.6% | -$119K |
|
546
Dorman Products
DORM
$4.22B
| $21.7M | 0.01% |
224,989
-1,232
| -0.5% | -$106K |
|
547
Patria Investments
PAX
$1.72B
| $21.6M | 0.01% |
1,458,013
+3,293
| +0.2% | +$48.3K |
|
548
AST SpaceMobile
ASTS
$15.8B
| $21.6M | 0.01% |
7,450,467
+5,046,667
| +210% | +$16.9M |
|
549
Halozyme
HALO
$9.88B
| $21.6M | 0.01% |
531,125
+102,911
| +24% | +$3.86M |
|
550
Blackrock
BLK
$167B
| $21.4M | 0.01% |
25,652
-4,591
| -15% | -$3.69M |
|
Similar funds
Janus Henderson Group's Q1 2024 Portfolio in Review
As of Q1 2024, Janus Henderson Group held 2,613 positions worth $183B, up 9.3% from $168B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Janus Henderson Group's Q1 2024 filing shows 67 new, 1,353 increased, 903 reduced and 85 closed positions. Its largest new stake was CG Oncology: 1,521,432 shares worth $66.8M. The largest sale was Abbott, an estimated $592M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 33% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q1 2024 buy was CG Oncology: 1,521,432 shares worth $66.8M.
- Janus Henderson Group added most to Oracle in Q1 2024, an estimated $881M increase.
- Janus Henderson Group's biggest Q1 2024 reduction was Abbott, cutting an estimated $592M.
- Janus Henderson Group fully exited Immunogen Inc in Q1 2024, selling an estimated $327M.
- Janus Henderson Group's ten largest holdings make up 28% of its $183B portfolio in Q1 2024.
- Janus Henderson Group opened 67 new positions and closed 85 in Q1 2024.
- Janus Henderson Group's portfolio value rose 9.3% quarter-over-quarter to $183B.
Based on Janus Henderson Group's 13F filing for Q1 2024, filed 15 May 2024.